Table 2 Outcomes, loss to follow-up, and mortality rates of Standardized Pediatric Expedited Encounters for ART Drugs Initiative (SPEEDI) patients (n = 1164)

% Good outcomes (n)

     -Active in care (n)

     -Transferred out (n)

98.3% (1144/1164)

     −91.3% (1063/1164)

     −7.0% (81/1164)

% Poor outcomes (n)

     -Died (n)

     -Lost-to-follow up (n)

1.2% (14/1164)

     −1.1% (13/1164)

     −0.6% (7/1164)

Mortality rate

0.61 deaths per 100 patient-years